Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene that every GLP-1 compound targets), MC4R (a melanocortin receptor central to satiety), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the metabolic terrain a clinician is prescribing into
Research and clinical experience suggest that IV NAD+ produces a sharp but short-lived spike in plasma levels that does not reliably translate to intracellular increases, which is where the therapeutic effect actually happens
(A spokesperson for the AAO told Allure they are not currently aware of any cases of vision loss caused by the procedure.) A 2020 report on the procedure published by the Ophthalmological Society of the United Kingdom was generally bullish on the procedure, but noted a rare complication involving an eye and brain disease-causing parasite
In the same press release, she added, GLP-1 users face specific nutritional challenges and finding products tailored to these needs can be challenging
In our office, we had a patient who had come in for her appointment after she had just had a gluten exposure (and her reactions were severe)
